| Market Cap | ₹6,716Cr |
| ROE | 11.72% |
| P/E Ratio(TTM) | 28.01 |
| EPS(TTM) | 26.45 |
| P/B Ratio | 3.28 |
| Dividend Yield | 0.67% |
| Industry P/E | 33.26 |
| Book Value | 225.73 |
| Debt to Equity | 0.32 |
| Face Value | 5 |
| Parent Organisation | Aarti Pharmalabs |
| Managing Director | Smt. Hetal Gogri Gala, Shri Narendra J. Salvi |
| Founded | 2019 |
| NSE Symbol | AARTIPHARM |
| FUND NAME | AUM(%) |
|---|---|
| ICICI Prudential Children's Fund Direct Growth | 0.49% |
| HDFC Multi Cap Fund Direct Growth | 0.15% |
| HDFC Large and Mid Cap Fund Direct Growth | 0.02% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.25 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.30 | ||
| Wockhardt | NA (0.00%) | -427.29 | ||
| Cohance Lifesciences | NA (0.00%) | 65.51 |